Clinical Study on the Prevention of Oxaliplatin-Induced Neurotoxicity with Guilongtongluofang: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Table 3

Objective tumor response in the trial group and the control group.

Group	𝑛	CR (%)	PR (%)	SD (%)	PG (%)	𝑃 value
Trial group	60	2 (3.3)	24 (40.0)	28 (46.7)	6 (10)	0.72
Control group	60	2 (3.3)	19 (31.7)	32 (53.3)	7 (11.7)

CR: complete response; PR: partial response; SD: stable disease; PG: progression.